U.S. Markets closed
  • S&P 500

    4,401.46
    -20.84 (-0.47%)
     
  • Dow 30

    35,058.52
    -85.79 (-0.24%)
     
  • Nasdaq

    14,660.58
    -180.14 (-1.21%)
     
  • Russell 2000

    2,191.83
    -25.09 (-1.13%)
     
  • Crude Oil

    71.96
    +0.31 (+0.43%)
     
  • Gold

    1,799.00
    -0.80 (-0.04%)
     
  • Silver

    24.73
    +0.08 (+0.33%)
     
  • EUR/USD

    1.1820
    +0.0013 (+0.1064%)
     
  • 10-Yr Bond

    1.2340
    -0.0420 (-3.29%)
     
  • Vix

    19.36
    +1.78 (+10.13%)
     
  • GBP/USD

    1.3880
    +0.0056 (+0.4067%)
     
  • USD/JPY

    109.7810
    +0.0140 (+0.0128%)
     
  • BTC-USD

    39,225.06
    +1,619.16 (+4.31%)
     
  • CMC Crypto 200

    898.78
    +22.55 (+2.57%)
     
  • FTSE 100

    6,996.08
    -29.35 (-0.42%)
     
  • Nikkei 225

    27,970.22
    +136.93 (+0.49%)
     

Raytheon's IDS Unit Wins $2.27B Deal to Support KSA Military

·3 min read

Raytheon Technologies Corp.’s RTX Integrated Defense Systems unit recently secured a production contract worth $2.27 billion under the Foreign Military Sales (FMS) program. Per the terms, the company will provide seven Army/Navy Transportable Surveillance and Control Model 2 radars, radar spares, sustainment services and initial contractor logistics support services to the Saudi Arabian (KSA) military.

Work related to the deal will be executed in Woburn, MA, with an estimated completion date of Aug 31, 2027. The contract was awarded by the Missile Defense Agency, Redstone Arsenal, AL.

Recent Merger to Create Strong Impact

In April, Raytheon merged with United Technologies to form Raytheon Technologies, thus creating the world's most advanced aerospace and defense systems provider. The combined entity expects to introduce breakthrough technologies at an accelerated pace across high-value areas, such as hypersonics, directed energy, avionics and cyber security, in the days to come. The merger has evidently set a more robust foundation for the new company in acquiring major contracts, similar to the latest one.

What Favors Raytheon Technologies?

Against the backdrop of the heightening geopolitical uncertainties around the world, a number of developing countries have significantly increased their defense spending. This, in turn, has bolstered the demand for advanced military surveillance radars in recent times. As the United States is the leading weapon exporter, its defense contractors enjoy a dominant position in the defense space. Raytheon Technologies is, notably, one such contractor as it witnesses frequent flow of contracts from the Pentagon and its foreign allies.

Interestingly, per a report by Markets and Markets, the global military radar market is projected to see a CAGR of 3.38%, from $13.1 billion in 2017 to $15.4 billion by 2022. The growth will be fueled by increasing R&D activities for the development of military radars with longer detection range combined with the growth in the defense expenditure of emerging economies, including Saudi Arabia. Such impressive projections will also benefit other military radar manufacturers, such as Lockheed Martin LMT and Northrop Grumman NOC, in the time ahead.

Notably, Raytheon Technologies significantly invests in the development of advanced next-generation radars and sensors equipped to detect, track and identify threats quickly.

Price Movement

In a year’s time, shares of Raytheon Technologies have lost 55% compared with the industry’s 40.1% decline.



Zacks Rank & Key Picks

Raytheon Technologies currently carries a Zacks Rank #4 (Sell).

A better-ranked stock in the same sector is Embraer S.A. ERJ, which holds a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Embraer delivered a positive earnings surprise of 14.93% in the trailing quarter. The company has a long-term (three to five years) earnings growth rate of 17%.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Northrop Grumman Corporation (NOC) : Free Stock Analysis Report
 
Lockheed Martin Corporation (LMT) : Free Stock Analysis Report
 
EmbraerEmpresa Brasileira de Aeronautica (ERJ) : Free Stock Analysis Report
 
Raytheon Technologies Corporation (RTX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research